» Articles » PMID: 6317348

Reduced Triiodothyronine Content in Liver but Not Pituitary of the Uremic Rat Model: Demonstration of Changes Compatible with Thyroid Hormone Deficiency in Liver Only

Overview
Journal Endocrinology
Specialty Endocrinology
Date 1984 Jan 1
PMID 6317348
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Intracellular thyroid hormone concentration and action were examined in the liver and the pituitary of a nephrectomized rat model (Nx); the results were compared with those obtained from control (C), thyroidectomized (Tx), and nephrectomized-thyroidectomized (NxTx) littermates. Based on the severity of the uremia, Nx rats were subdivided into Nx1 and Nx2 groups; the former included rats with serum urea nitrogen of less than 100 mg/dl and the latter rats with serum urea nitrogen greater than 100 mg/dl. A group of rats pair-fed to the Nx rats was also included (PF). In the liver, nuclear T3 content (picograms per g liver) and T3-receptor binding capacity (Cmax, picograms T3 per mg DNA) were measured. The respective results from all groups of rats were as follows (asterisks denote values differing from C with a P value less than 0.05): C, 308 +/- (SE) 45 and 121 +/- 11; Nx1, 245 +/- 43 and 85 +/- 15; Nx2, 163 +/- 19 and 74 +/- 7; Tx, 43 +/- 11 and 91 +/- 10; NxTx, 33 +/- 10 and 54 +/- 6; and PF, 237 +/- 20 and 121 +/- 9. T3 receptor binding affinity (Ka), ranging from 3.62-5.28 X 10(9) M-1, was not significantly different among the six groups of rats. In the pituitary, T3 content (picograms per mg pituitary) was reduced only in the Tx rats, being 3.13 +/- 0.89 as compared to 7.04 +/- 1.48 in the C rats (P less than 0.05). In the Nx1, Nx2, and PF rats, pituitary T3 contents were 9.81 +/- 3.22, 13.01 +/- 3.60, and 7.83 +/- 1.08, respectively, and were not different from the C rats. Serum TSH was reciprocally elevated only in the Tx rats. The reduction in hepatic nuclear T3 content and T3-Cmax in the Nx2 rats is consistent with the presence of selective tissue deficiency of thyroid hormone. This is in agreement with the observation of reduced activity of two liver enzymes known to be under thyroid hormone regulation. The pituitary, however, had normal T3 content, suggesting a dissociation in thyroid hormone-dependent metabolic status between a peripheral tissue (liver) and the pituitary. This explains the failure to observe an increase in the serum TSH level, a manifestation of reduced intracellular rather than serum T3 concentration. Decreased food intake appeared not to be the cause of thyroid hormone abnormalities observed in uremia, as PF rats failed to manifest the changes found in Nx rats.

Citing Articles

Thyroid function, renal events and mortality in chronic kidney disease patients: the German Chronic Kidney Disease study.

Schultheiss U, Steinbrenner I, Nauck M, Schneider M, Kotsis F, Baid-Agrawal S Clin Kidney J. 2021; 14(3):959-968.

PMID: 34349984 PMC: 8328092. DOI: 10.1093/ckj/sfaa052.


Abnormalities of Thyroid Hormone Metabolism during Systemic Illness: The Low T3 Syndrome in Different Clinical Settings.

Neto A, Zantut-Wittmann D Int J Endocrinol. 2016; 2016:2157583.

PMID: 27803712 PMC: 5075641. DOI: 10.1155/2016/2157583.


Evaluation of oxidative stress and thyroid hormone status in hemodialysis patients in Gorgan.

Velayeti J, Mansourian A, Mojerloo M, Marjani A Indian J Endocrinol Metab. 2016; 20(3):348-53.

PMID: 27186552 PMC: 4855963. DOI: 10.4103/2230-8210.179986.


Importance of specific reference values for evaluation of the deteriorating thyroid function in patients with end-stage renal disease on hemodialysis.

Sanai T, Okamura K, Kishi T, Miyazono M, Ikeda Y, Kitazono T J Endocrinol Invest. 2014; 38(1):47-56.

PMID: 24996935 DOI: 10.1007/s40618-014-0121-6.


Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Rhee C, Brent G, Kovesdy C, Soldin O, Nguyen D, Budoff M Nephrol Dial Transplant. 2014; 30(5):724-37.

PMID: 24574542 PMC: 4425477. DOI: 10.1093/ndt/gfu024.